Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Developmental trajectory of the mouse transcriptome following placental allopregnanolone insufficiency in the somatosensosry cortex, hippocampus and cerebellum

ABSTRACT: This study investigates the developmental impact of placental allopregnanolone (ALLO) insufficiency on the mouse brain transcriptome in an age-, sex-, and region-specific manner. We generated mice with reduced ALLO levels by specifically deleting the gene encoding the synthetic enzyme for ALLO (Akr1c14) in trophoblasts using an Akr1c14-floxed mouse with a Cyp19a-Cre mouse. The somatosensory cortex, hippocampus, and cerebellum of both WT and plKO mice were collected from males and females at postnatal days 0, 7, 15, and 30. Libraries were prepared using the Illumina TruSeq Stranded mRNA Library prep kit and sequenced on an Illumina NovaSeq sequencer with 2 x 100 bp paired-end cycles. The analysis reveals sex- and region-specific transcriptomic changes following reduced placental ALLO, with differentially expressed genes associated with inflammatory signaling.

ORGANISM(S): Mus musculus

PROVIDER: GSE306583 | GEO | 2025/12/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Long-term impact of placental allopregnanolone insufficiency on the mouse transcriptome of cerebral cortex, hippocampus, hypothalamus and cerebellum

Project description:Goal: To test the long-term influence of placental allopregnanolone (ALLO) loss on mouse brain transcriptome, in a sex- and region-specficic manner. Methods: We deleted the gene encoding the synthetic enzyme for ALLO (Akr1c14) specifically in trophoblasts by crossing Akr1c14-floxed mice with Cyp19a-Cre mice (plKO mice). Region-specific mRNA profiles of 30-day old WT and plKO mice were generated by 3'mRNA sequencing, in triplicate, using Illumina HiSeq 2500. Results: Our RNA sequencing analysis reveals that placental ALLO withdrawal is associated with region- and sex-specific gene expression changes. The differentially expressed genes are notably associated with myelination and autism spectrum disorders. Conclusions: We show that placental ALLO insufficiency is associated with long-term changes in gene expression in the mouse brain in a sex- and region-specific manner.

2021-04-28 | GSE173440 | GEO

Allopregnanolone is neuroprotective in hypoxic-ischemic injury of the immature brain

Project description:Hypoxic-ischemic (HI) brain injury in premature infants causes major cognitive deficits and cerebral palsy (CP). Premature infants are devoid of a placental supply of Allopregnanolone (ALLO). ALLO is essential for brain growth and neuronal and glial cell survival. Goals and objectives: To assess whether ALLO supplementation mitigates hypoxic-ischemic (HI) brain injury. To conduct a comparative analysis of RNA sequencing between ALLO-treated HI mice and untreated HI mice. To elucidate the mechanism of action of ALLO in the context of HI brain injury.Methods: A neonate mouse model of HI was treated with 3 doses of ALLO (10mg/kg/dose IP) on P5, P8, and P11 or saline. Molecular, biochemical, histopathological, and transcriptome studies were done on P12-P14. Others were examined at P60 for neurobehavioral analysis. Results: ALLO-treated HI mice showed significant improvement in neuro-regeneration, myelination, motor function, coordination, learning, and memory, along with significant attenuation of neuro-inflammation. RNA sequencing analysis showed that the ALLO-treated HI group had a significant downregulation of inflammatory responsive genes, reduced glutamate excitotoxicity, improved neurogenesis, and improved neural repair, restoring neural integrity and cognitive function. Using electron microscopy, mitochondrial ultrastructure in hippocampal neurons showed small, fragmented mitochondria, with loss of mitochondrial membrane and cristae in HI group, while ALLO protected mitochondrial ultrastructure after HI exposure. Conclusion: ALLO is a unique natural neurotherapeutic steroid in HI injury through promoting neurogenesis, neurodegeneration, and oligodendrogenesis, reducing neuroinflammation and glutamate excitotoxicity, and preserving mitochondrial structure and function.

2025-07-16 | GSE302721 | GEO

Developmental trajectory of the mouse transcriptome following placental allopregnanolone insufficiency in the somatosensosry cortex, hippocampus and cerebellum

Project description:Developmental trajectory of the mouse transcriptome following placental allopregnanolone insufficiency in the somatosensosry cortex, hippocampus and cerebellum

| PRJNA1311349 | ENA

Long-term impact of placental allopregnanolone insufficiency on the mouse transcriptome of cerebral cortex, hippocampus, hypothalamus and cerebellum

Project description:Long-term impact of placental allopregnanolone insufficiency on the mouse transcriptome of cerebral cortex, hippocampus, hypothalamus and cerebellum

| PRJNA725533 | ENA

The acute stress response is mediated by prefrontal 5α-reductase 2 in males via allopregnanolone synthesis

Project description:Acute stress triggers rapid brain responses, including increased allopregnanolone (AP) synthesis via 5α-reductase (5αR). However, the involvement of this enzyme in stress response remains elusive. Here, we investigated the roles of the two major 5αR isoenzymes in acute stress. Acute stress increased mRNA and protein levels of 5αR2, but not 5αR1, in the medial prefrontal cortex (mPFC) of male, but not female, rats. Targeted mPFC downregulation of 5αR2, but not 5αR1, markedly reduced the responsiveness of males, but not females, to both stressful and arousing stimuli. Similar sex differences were observed in 5αR2 knockout rats. While 5αR1 regulated AP synthesis under baseline conditions, 5αR2 enabled this process in response to acute stress. Single-nucleus transcriptomic analyses revealed that 5αR2 enabled stress-induced protein synthesis in pyramidal neurons and glia of the mPFC. These findings underscore the pivotal role of 5αR2 in shaping sex-related differences in acute stress reactivity.

2024-12-23 | GSE267559 | GEO

Allopregnanolone alters the gene expression profile of human glioblastoma cells

Project description:Glioblastomas (GBM) are one of the most frequent and aggressive brain tumors. In these malignancies, progesterone (P4) promotes proliferation, migration, and invasion. The P4 metabolite allopregnanolone (3α-THP) similarly promotes cell proliferation in the U87 human GBM cell line. Here, we evaluated global changes in gene expression of U87 cells treated with 3α-THP, P4, and the 5α-reductase inhibitor, finasteride (F).

2018-02-11 | GSE108998 | GEO

Allopregnanolone alters the gene expression profile of human glioblastoma cells

Project description:Allopregnanolone alters the gene expression profile of human glioblastoma cells

| PRJNA429367 | ENA

Gene expression profiling indicates inflammatory pathways involved in IUGR due to placental insufficiency

Project description:Intrauterine growth restriction (IUGR) represents a major obstetric challenge with perinatal complications and a risk factor of developing disease in adult life. Placental insufficiency is one of the common features accompanying IUGR. The aim of this study was to evaluate global placental gene expression profile in IUGR compared to normal pregnancies. Placental samples were collected by eight IUGR pregnancies with placental insufficiency ascertained by Doppler and eight healthy controls. A 30K Human Genome Survey Microarray v.2.0 (Applied Biosystems) was used to evaluate global gene expression profile. Principal component analysis showed good separation in terms of gene expression patterns between the groups. Pathway analysis with Bonferroni correction for multiple testing showed significant (p<0.05) up-regulation of inflammation mediated by chemokine and cytokine signalling pathway in the IUGR placentas. Genes involved in metabolism of glucocorticoids (HSD11B1 and DHRS2) were found differentially expressed. We found no imprinted genes to be differentially expressed and only one gene involved in epigenetic modifications (MBD3) to be down-regulated in the IUGR placentas, indicating that IUGR due to placental insufficiency is not associated to placental imprinting. Subgroup analysis between pure IUGR and IUGR with preeclampsia placentas showed only 27 differentially expressed genes suggesting common pathophysiology. Eight placental samples from normal human placenta compared to eight human placental samples from patients with intrauterine growth restrictions due to placental insufficiency

2008-08-01 | E-GEOD-12216 | biostudies-arrayexpress

RNA-seq melanoma

Project description:Using a chromatin regulator-focused shRNA library, we found that suppression of sex determining region Y-box 10 (SOX10) in melanoma causes resistance to BRAF and MEK inhibitors. To investigate how SOX10 loss leads to drug resistance, we performed transcriptome sequencing (RNAseq) of both parental A375 (Ctrl. PLKO) and A375-SOX10KD (shSOX10-1, shSOX10-2) cells. To ask directly whether SOX10 is involved indrug resistance in BRAF(V600E) melanoma patients, we isolated RNA from paired biopsies from melanoma patients (pre- and post- treatment) , that had gained BRAF or MEK inhibitor resistance . We performed RNAseq analysis to determine changes in transcriptome upon drug resistance.

2014-01-04 | GSE50535 | GEO

Single-cell RNA sequencing revealed the role of the Th17 pathway in the development of anti HLA antibodies in a highly sensitized mouse model

Project description:The aim of this study is to investigate the specific pathway involved in HLA sensitization using single-cell RNA sequencing analysis and an allo-sensitized mouse model developed with an HLA.A2 transgenic mouse. For sensitization, wild-type C57BL/6 mouse received two skin grafts from C57BL/6-Tg (HLA-A2.1)1Enge/J mouse (allogeneic mouse (ALLO)). For syngeneic control (SYN), skin grafts were transferred from C57BL/6 to C57BL/6. We performed single-cell RNA sequencing analysis on splenocytes isolated from ALLO and SYN mice and compared the gene expression between them. We generated 9,190 and 8,890 single-cell transcriptomes from ALLO and SYN control mice, respectively. Five major cell types (B-cells, T-cells, NK cells, macrophages, and neutrophils) and their transcriptome data were annotated according to the representative differentially expressed genes of each cell cluster. The percentage of B-cells was higher in allogeneic mouse than it was in syngeneic control mouse. KEGG enrichment analyses indicated that the highly expressed genes in the B-cells from ALLO mouse were mainly associated with antigen processing and presentation pathways, allograft rejection, and the Th17 cell differentiation pathway. Upregulated genes in the T-cells of ALLO mouse were involved in the IL-17 signaling pathway. The ratio of Th17 cluster and Treg cluster was increased in the ALLO mouse. On flow cytometry, the percentage of Th17 (IL-17+/CD4+ T) cells was higher and regulatory T cells (FOXP3+/CD4+ T) was lower in the ALLO mouse compared to those in the SYN mouse. Our results indicate that not only the B cell lineage, but also the Th17 cells and their cytokine (IL-17) are involved in the sensitization to HLA.

2024-08-15 | GSE240862 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data